Agomelatine beyond Borders: Current Evidences of Its Efficacy in Disorders Other than Major Depression
AbstractAgomelatine, a melatonergic antidepressant with a rapid onset of action, is one of the most recent drugs in the antidepressant category. Agomelatine’s antidepressant actions are attributed to its sleep-promoting and chronobiotic actions mediated by MT1 and MT2 receptors present in the suprachiasmatic nucleus, as well as to its effects on the blockade of 5-HT2c receptors. Blockade of 5-HT2c receptors causes release of both noradrenaline and dopamine at the fronto-cortical dopaminergic and noradrenergic pathways. The combined actions of agomelatine on MT1/MT2 and 5-HT2c receptors facilitate the resynchronization of altered circadian rhythms and abnormal sleep patterns. Agomelatine appeared to be effective in treating major depression. Moreover, evidence exists that points out a possible efficacy of such drug in the treatment of bipolar depression, anxiety disorders, alcohol dependence, migraines etc. Thus, the aim of this narrative review was to elucidate current evidences on the role of agomelatine in disorders other than major depression. View Full-Text
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
De Berardis, D.; Fornaro, M.; Serroni, N.; Campanella, D.; Rapini, G.; Olivieri, L.; Srinivasan, V.; Iasevoli, F.; Tomasetti, C.; De Bartolomeis, A.; Valchera, A.; Perna, G.; Mazza, M.; Di Nicola, M.; Martinotti, G.; Di Giannantonio, M. Agomelatine beyond Borders: Current Evidences of Its Efficacy in Disorders Other than Major Depression. Int. J. Mol. Sci. 2015, 16, 1111-1130.
De Berardis D, Fornaro M, Serroni N, Campanella D, Rapini G, Olivieri L, Srinivasan V, Iasevoli F, Tomasetti C, De Bartolomeis A, Valchera A, Perna G, Mazza M, Di Nicola M, Martinotti G, Di Giannantonio M. Agomelatine beyond Borders: Current Evidences of Its Efficacy in Disorders Other than Major Depression. International Journal of Molecular Sciences. 2015; 16(1):1111-1130.Chicago/Turabian Style
De Berardis, Domenico; Fornaro, Michele; Serroni, Nicola; Campanella, Daniela; Rapini, Gabriella; Olivieri, Luigi; Srinivasan, Venkataramanujam; Iasevoli, Felice; Tomasetti, Carmine; De Bartolomeis, Andrea; Valchera, Alessandro; Perna, Giampaolo; Mazza, Monica; Di Nicola, Marco; Martinotti, Giovanni; Di Giannantonio, Massimo. 2015. "Agomelatine beyond Borders: Current Evidences of Its Efficacy in Disorders Other than Major Depression." Int. J. Mol. Sci. 16, no. 1: 1111-1130.